CPRX

As of 2026-09-10, CPRX scores 55out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. CPRX trades at $31.49, 24% below the band floor.

CPRX scores 55 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 55. Its strongest factor is volume at 90 (exceptional), where trading volume confirms genuine accumulation, followed by value at 81. The weakest is momentum at 36, where price trend is the soft spot. Among Healthcare stocks it ranks in roughly the top 19% of the Healthcare names the model scores.

On valuation, CPRX is priced near the floor of its own recent range — the cheap end on the model's valuation read. The profile is lopsided — a few factors carry it while others drag, so the composite masks real disagreement underneath. The blended composite before the macro overlay was 57. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on CPRX, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where CPRX sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for CPRX runs $41.57–$52.90. Current price $31.49 sits 24% below the band floor. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.